Steven L. Krill Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Steven L. Krill.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Steven L. Krill. Steven L. Krill is Chief Scientific Officer in EAGLE PHARMACEUTICALS, INC. ($EGRX) and EVP & Chief Scientific Officer in EAGLE PHARMACEUTICALS, INC. ($EGRX).
Latest Insider Trading Transactions of Steven L. Krill
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 09 2018 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Option Exercise | A | 0.00 | 9,000 | 0 | 9,000 | |
| Jan 09 2018 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Option Exercise | A | 59.14 | 15,000 | 887,100 | 15,000 | |
| Jan 09 2018 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Grant | A | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
| Mar 24 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Option Exercise | M | 12.63 | 5,000 | 63,150 | 15,000 | |
| Mar 24 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Option Exercise | M | 12.67 | 2,025 | 25,657 | 4,850 | |
| Mar 24 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Option Exercise | M | 12.67 | 2,077 | 26,316 | 6,875 | |
| Mar 24 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Option Exercise | M | 4.42 | 5,023 | 22,202 | 457 | |
| Mar 24 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Sell | S | 82.06 | 7,025 | 576,489 | 0 | 7 K to 0 (-100.00 %) |
| Mar 24 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Buy | M | 12.63 | 5,000 | 63,150 | 7,025 | 2 K to 7 K (+246.91 %) |
| Mar 24 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Buy | M | 12.67 | 2,025 | 25,657 | 2,025 | 0 to 2 K |
| Mar 24 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Sell | S | 80.09 | 7,100 | 568,641 | 0 | 7.1 K to 0 (-100.00 %) |
| Mar 24 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Buy | M | 12.67 | 2,077 | 26,316 | 7,100 | 5 K to 7.1 K (+41.35 %) |
| Mar 24 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Buy | M | 4.42 | 5,023 | 22,202 | 5,023 | 0 to 5 K |
| Jan 06 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Option Exercise | A | 84.92 | 42,000 | 3,566,640 | 42,000 | |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Option Exercise | M | 46.09 | 5,127 | 236,303 | 53,464 | |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Option Exercise | M | 46.09 | 5,126 | 236,257 | 58,591 | |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Option Exercise | M | 46.09 | 7,569 | 348,855 | 63,717 | |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Option Exercise | M | 12.63 | 2,683 | 33,886 | 20,000 | |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Option Exercise | M | 12.63 | 10,000 | 126,300 | 22,683 | |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Option Exercise | M | 12.63 | 7,317 | 92,414 | 32,683 | |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Option Exercise | M | 12.67 | 2,683 | 33,994 | 8,952 | |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Option Exercise | M | 12.67 | 6,270 | 79,441 | 11,635 | |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Option Exercise | M | 4.42 | 3,730 | 16,487 | 5,480 | |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Sell | S | 78.61 | 5,127 | 403,018 | 0 | 5.1 K to 0 (-100.00 %) |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Buy | M | 46.09 | 5,127 | 236,303 | 5,127 | 0 to 5.1 K |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Sell | S | 76.78 | 5,126 | 393,571 | 0 | 5.1 K to 0 (-100.00 %) |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Buy | M | 46.09 | 5,126 | 236,257 | 5,126 | 0 to 5.1 K |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Sell | S | 77.17 | 7,569 | 584,135 | 0 | 7.6 K to 0 (-100.00 %) |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Buy | M | 46.09 | 7,569 | 348,855 | 7,569 | 0 to 7.6 K |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Sell | S | 77.17 | 2,683 | 207,060 | 0 | 2.7 K to 0 (-100.00 %) |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Buy | M | 12.63 | 2,683 | 33,886 | 2,683 | 0 to 2.7 K |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Sell | S | 76.69 | 10,000 | 766,876 | 0 | 10 K to 0 (-100.00 %) |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Buy | M | 12.63 | 10,000 | 126,300 | 10,000 | 0 to 10 K |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Sell | S | 75.61 | 7,317 | 553,213 | 0 | 7.3 K to 0 (-100.00 %) |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Buy | M | 12.63 | 7,317 | 92,414 | 7,317 | 0 to 7.3 K |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Sell | S | 75.61 | 2,683 | 202,853 | 0 | 2.7 K to 0 (-100.00 %) |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Buy | M | 12.67 | 2,683 | 33,994 | 2,683 | 0 to 2.7 K |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Sell | S | 74.79 | 6,270 | 468,931 | 0 | 6.3 K to 0 (-100.00 %) |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Buy | M | 12.67 | 6,270 | 79,441 | 6,270 | 0 to 6.3 K |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Sell | S | 74.79 | 3,730 | 278,965 | 0 | 3.7 K to 0 (-100.00 %) |
| Jan 04 2017 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Buy | M | 4.42 | 3,730 | 16,487 | 3,730 | 0 to 3.7 K |
| Dec 15 2016 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Option Exercise | M | 4.42 | 10,000 | 44,200 | 9,210 | |
| Dec 15 2016 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Sell | S | 73.62 | 10,000 | 736,163 | 0 | 10 K to 0 (-100.00 %) |
| Dec 15 2016 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Buy | M | 4.42 | 10,000 | 44,200 | 10,000 | 0 to 10 K |
| Dec 02 2016 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Option Exercise | M | 4.42 | 1,307 | 5,777 | 19,210 | |
| Dec 02 2016 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Option Exercise | M | 8.78 | 2,530 | 22,213 | 0 | |
| Dec 02 2016 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Option Exercise | M | 8.78 | 1,950 | 17,121 | 0 | |
| Dec 02 2016 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Option Exercise | M | 8.78 | 200 | 1,756 | 2,530 | |
| Dec 02 2016 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Sell | S | 80.00 | 1,307 | 104,560 | 0 | 1.3 K to 0 (-100.00 %) |
| Dec 02 2016 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Buy | M | 4.42 | 1,307 | 5,777 | 1,307 | 0 to 1.3 K |
| Dec 02 2016 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Sell | S | 80.00 | 2,530 | 202,400 | 0 | 2.5 K to 0 (-100.00 %) |
| Dec 02 2016 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Buy | M | 8.78 | 2,530 | 22,213 | 2,530 | 0 to 2.5 K |
| Dec 02 2016 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Sell | S | 80.00 | 1,950 | 156,000 | 0 | 2 K to 0 (-100.00 %) |
| Dec 02 2016 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Buy | M | 8.78 | 1,950 | 17,121 | 1,950 | 0 to 2 K |
| Dec 02 2016 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Sell | S | 80.00 | 200 | 16,000 | 0 | 200 to 0 (-100.00 %) |
| Dec 02 2016 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Buy | M | 8.78 | 200 | 1,756 | 200 | 0 to 200 |
| Jan 05 2016 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | Chief Scientific Of ... | Option Exercise | A | 86.15 | 62,100 | 5,349,915 | 62,100 | |
| Jun 18 2015 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | Chief Scientific Of ... | Option Exercise | M | 4.42 | 1,400 | 6,188 | 20,517 | |
| Jun 18 2015 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | Chief Scientific Of ... | Option Exercise | M | 8.78 | 2,730 | 23,969 | 2,730 | |
| Jun 18 2015 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | Chief Scientific Of ... | Option Exercise | M | 8.78 | 5,850 | 51,363 | 1,950 | |
| Jun 18 2015 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | Chief Scientific Of ... | Sell | S | 81.60 | 1,400 | 114,240 | 0 | 1.4 K to 0 (-100.00 %) |
| Jun 18 2015 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | Chief Scientific Of ... | Buy | M | 4.42 | 1,400 | 6,188 | 1,400 | 0 to 1.4 K |
| Jun 18 2015 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | Chief Scientific Of ... | Sell | S | 81.60 | 2,730 | 222,768 | 0 | 2.7 K to 0 (-100.00 %) |
| Jun 18 2015 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | Chief Scientific Of ... | Buy | M | 8.78 | 2,730 | 23,969 | 2,730 | 0 to 2.7 K |
| Jun 18 2015 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | Chief Scientific Of ... | Sell | S | 81.60 | 5,850 | 477,360 | 0 | 5.9 K to 0 (-100.00 %) |
| Jun 18 2015 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | Chief Scientific Of ... | Buy | M | 8.78 | 5,850 | 51,363 | 5,850 | 0 to 5.9 K |
| Mar 17 2015 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | Chief Scientific Of ... | Option Exercise | A | 46.09 | 71,286 | 3,285,572 | 71,286 | |
| Aug 27 2014 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | Chief Scientific Of ... | Option Exercise | A | 12.63 | 40,000 | 505,200 | 40,000 | |
| May 02 2014 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | Chief Scientific Of ... | Option Exercise | A | 12.67 | 17,905 | 226,856 | 17,905 |
Page: 1